Sino Biopharmaceutical Limited (HKG:1177)

Sino Biopharmaceutical Revenue

In the year 2025, Sino Biopharmaceutical had annual revenue of 31.83B CNY with 10.28% growth. Sino Biopharmaceutical had revenue of 14.26B in the half year ending December 31, 2025.

• Revenue: 31.83B CNY
• Revenue Growth: +10.28%
• P/S Ratio: 2.51
• Revenue / Employee: 1.49M CNY
• Employees: 21,435
• Market Cap: 88.98B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	31.83B	2.97B	10.28%
Dec 31, 2024	28.87B	2.67B	10.18%
Dec 31, 2023	26.20B	173.25M	0.67%
Dec 31, 2022	26.03B	-835.19M	-3.11%
Dec 31, 2021	26.86B	3.21B	13.59%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

May 27, 2026

Data Sources Report a data error